These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2749602)

  • 1. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits.
    Holvoet P; Stassen JM; Hashimoto Y; Spriggs D; Devos P; Collen D
    Thromb Haemost; 1989 Apr; 61(2):307-13. PubMed ID: 2749602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombus imaging with an I-123-labeled F(ab')2 fragment of an anti-human fibrin monoclonal antibody in a rabbit model.
    Hashimoto Y; Stassen JM; Leclef B; De Roo M; Vandecruys A; Melin J; Verhoeven-Mester D; Trouet A; Collen D
    Radiology; 1989 Apr; 171(1):223-6. PubMed ID: 2928528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model.
    Collen D; Dewerchin M; Rapold HJ; Lijnen HR; Stassen JM
    Circulation; 1990 Nov; 82(5):1744-53. PubMed ID: 2121385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer.
    Bulens F; Vandamme AM; Bernar H; Nelles L; Lijnen RH; Collen D
    Eur J Biochem; 1991 Jan; 195(1):235-42. PubMed ID: 1899382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin.
    Dewerchin M; Lijnen HR; Van Hoef B; De Cock F; Collen D
    Eur J Biochem; 1989 Oct; 185(1):141-9. PubMed ID: 2530085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antifibrin monoclonal antibody useful in immunoscintigraphic detection of thrombi.
    Wasser MN; Koppert PW; Arndt JW; Emeis JJ; Feitsma RI; Pauwels EK; Nieuwenhuizen W
    Blood; 1989 Aug; 74(2):708-14. PubMed ID: 2665852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo penetration of experimentally produced clots by monoclonal antibodies.
    McEvoy FJ; Edgell TA; Webbon PM; Gaffney PJ
    Thromb Haemost; 2000 Jun; 83(6):882-6. PubMed ID: 10896242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis.
    Declerck PJ; Mombaerts P; Holvoet P; De Mol M; Collen D
    Thromb Haemost; 1987 Dec; 58(4):1024-9. PubMed ID: 3127914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti D dimer monoclonal antibodies: a possible scintigraphic agent for immunodetection of thrombi.
    Scopinaro F; Di Loreto M; Banci M; Schillaci O; Di Macio L; de Santis R; Anastasi AM; Ciancarella W; Centi Colella A; Mele A
    Nucl Med Commun; 1992 Oct; 13(10):723-9. PubMed ID: 1491836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusion.
    Holvoet P; Lijnen HR; Collen D
    Blood; 1986 May; 67(5):1482-7. PubMed ID: 3083892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer test.
    Bach-Gansmo ET; Godal HC; Skjønsberg OH
    Thromb Res; 1998 Nov; 92(3):125-34. PubMed ID: 9806364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of a recombinant murine monoclonal antibody directed against human fibrin fragment-D dimer.
    Vandamme AM; Bulens F; Bernar H; Nelles L; Lijnen RH; Collen D
    Eur J Biochem; 1990 Sep; 192(3):767-75. PubMed ID: 2209622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogen.
    Koppert PW; Koopman J; Haverkate F; Nieuwenhuizen W
    Blood; 1986 Aug; 68(2):437-41. PubMed ID: 3730608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neoantigenic determinant in the D-dimer fragment of fibrin.
    Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.
    Kurokawa T; Iwasa S; Kakinuma A; Stassen JM; Lijnen HR; Collen D
    Thromb Haemost; 1991 Dec; 66(6):684-93. PubMed ID: 1796414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.